Business Combination (Tables)

12 Months Ended

Mar. 31, 2025

Business Combinations [Abstract]

Schedule of assets acquired and liabilities assumed

The Company's final allocation of the purchase price to the assets acquired, liabilities assumed, and noncontrolling interest recognized and redeemable as of the Closing Date were as follows:

(In thousands)
Cash and cash equivalents	$	221
Accounts receivable		116
Materials and supplies		537
Operating lease right-of-use		3,063
Prepaid expenses and other assets		265
Property, plant, and equipment		24,584
Intangible assets		4,133
Goodwill		12,280
Total assets acquired		45,199
Accounts payable		1,252
Accrued expenses and other liabilities		112
Lease liabilities		3,063
Deferred income taxes		4,208
Deferred revenue		556
Total liabilities assumed		9,191
Total fair value of net assets acquired		36,008
Less: redeemable noncontrolling interest		(17,644	)
Total Adjusted Base Purchase Price	$	18,364

Schedule of net impact of the Acquisition on the Company's condensed consolidated statements of operations

The following is the net impact of the Amplex Acquisition on the Company's consolidated statements of operations since the Closing Date:

		For the Fiscal Year Ended March 31, 2025
	(In thousands)
Total revenue		$	9,366
Net loss from continuing operations		$	(453	)

Schedule of business acquisition, pro forma information

The following table represents the supplemental consolidated financial results of the Company on an unaudited pro forma basis, as if the acquisition had been consummated on April 1, 2023.

	(In thousands)
		For the Fiscal Year Ended March 31,
		2025 (Pro Forma)			2024 (Pro Forma)
Revenue		$	12,271		$	11,112
Net loss from continuing operations attributable to common shareholders before dividends			(9,249	)		(4,977	)
Net loss from continuing operations attributable to common shareholders		$	(9,249	)	$	(4,977	)
Net income (loss) from discontinued operations attributable to common shareholders			3,038			(14,703	)
Net loss attributable to common shareholders		$	(6,211	)	$	(19,680	)

Schedule of noncash investing and financing activities

The following table represents the supplemental schedule of noncash investing and financing activities:

	(In thousands)
	For the Fiscal Year Ended March 31,
	2025			2024
Supplemental schedule of noncash investing and financing activities
Fair value of Amplex assets acquired	$	45,199		$	-
Less: redeemable noncontrolling interest		(17,644	)		-
Less: cash paid for Amplex common stock		(18,364	)		-
Amplex liabilities assumed	$	9,191		$	-